Related Experiment Videos
[Re-evaluating neuroleptics: their antipsychotic properties?]
1Service de Psychiatrie, Université Paris XI, Hôpital Paul Brousse, Villejuif.
Presse Medicale (Paris, France : 1983)
|January 29, 1999
Summary
New antipsychotics offer improved efficacy and fewer side effects compared to traditional neuroleptics, particularly for productive schizophrenia symptoms. Long-term safety and cost-effectiveness require further investigation for these advanced treatments.
Area of Science:
- Pharmacology
- Neuroscience
Context:
- Traditional neuroleptics have limitations, including unsatisfactory response rates in ~25% of patients and significant neurological side effects.
- Antipsychotics represent a newer class of drugs with distinct receptor profiles.
Purpose:
- To compare the properties and clinical effects of traditional neuroleptics and newer antipsychotic medications.
- To highlight the advantages of antipsychotics, such as reduced extrapyramidal effects and efficacy for productive symptoms.
- To identify unresolved questions regarding the long-term use and cost-effectiveness of atypical antipsychotics.
Summary:
- Antipsychotics, unlike traditional neuroleptics, target receptors beyond dopamine, notably serotonin receptors.
- These newer agents exhibit fewer extrapyramidal side effects and are effective for productive symptoms in schizophrenia, with potential benefits for resistant cases.
- While precursors like sulpiride and derivatives like amisulpride exist, newer drugs like clozapine, risperidone, and olanzapine are also available, with more anticipated.
Impact:
- Antipsychotics offer a promising alternative for schizophrenia treatment, addressing limitations of older drugs.
- Further research is needed to establish the long-term efficacy, safety, and cost-benefit profile of these advanced medications for widespread clinical adoption.